BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,618 | -12.2% | 42,881 | +6.0% | 0.01% | 0.0% |
| Q2 2023 | $1,843 | +17.5% | 40,448 | +4.6% | 0.01% | +9.1% |
| Q1 2023 | $1,569 | -15.6% | 38,687 | +6.0% | 0.01% | -21.4% |
| Q4 2022 | $1,860 | -99.9% | 36,485 | +9.8% | 0.01% | -6.7% |
| Q3 2022 | $1,790,000 | -13.4% | 33,237 | +3.3% | 0.02% | -6.2% |
| Q2 2022 | $2,067,000 | -13.3% | 32,183 | +4.7% | 0.02% | +6.7% |
| Q1 2022 | $2,383,000 | -10.7% | 30,734 | -1.2% | 0.02% | -6.2% |
| Q4 2021 | $2,670,000 | +10.1% | 31,105 | +3.1% | 0.02% | 0.0% |
| Q3 2021 | $2,426,000 | +3.5% | 30,167 | +3.6% | 0.02% | 0.0% |
| Q2 2021 | $2,345,000 | -2.3% | 29,131 | +2.4% | 0.02% | -11.1% |
| Q1 2021 | $2,400,000 | +6.2% | 28,452 | +1.0% | 0.02% | +5.9% |
| Q4 2020 | $2,259,000 | +11.6% | 28,159 | +11.9% | 0.02% | -5.6% |
| Q3 2020 | $2,024,000 | +2.5% | 25,163 | -5.1% | 0.02% | -57.1% |
| Q2 2020 | $1,974,000 | -8.3% | 26,519 | 0.0% | 0.04% | +90.9% |
| Q1 2020 | $2,153,000 | +3.7% | 26,519 | +6.8% | 0.02% | +29.4% |
| Q4 2019 | $2,077,000 | -8.2% | 24,839 | -4.0% | 0.02% | -10.5% |
| Q3 2019 | $2,263,000 | +8.7% | 25,879 | +1.8% | 0.02% | +5.6% |
| Q2 2019 | $2,081,000 | +3.6% | 25,409 | +2.9% | 0.02% | 0.0% |
| Q1 2019 | $2,008,000 | +47.6% | 24,699 | +19.5% | 0.02% | +38.5% |
| Q4 2018 | $1,360,000 | -6.8% | 20,665 | +9.2% | 0.01% | +8.3% |
| Q3 2018 | $1,459,000 | +7.0% | 18,920 | +2.5% | 0.01% | +9.1% |
| Q2 2018 | $1,363,000 | +26.8% | 18,460 | +11.7% | 0.01% | +22.2% |
| Q1 2018 | $1,075,000 | +8.0% | 16,532 | +7.4% | 0.01% | +28.6% |
| Q4 2017 | $995,000 | -75.5% | 15,386 | -76.2% | 0.01% | -75.0% |
| Q3 2017 | $4,053,000 | -30.0% | 64,582 | -32.5% | 0.03% | -24.3% |
| Q2 2017 | $5,794,000 | -51.0% | 95,720 | -58.0% | 0.04% | -50.0% |
| Q1 2017 | $11,814,000 | +67.5% | 227,800 | +43.2% | 0.07% | +64.4% |
| Q4 2016 | $7,054,000 | +27.5% | 159,100 | +36.9% | 0.04% | +36.4% |
| Q3 2016 | $5,531,000 | -0.1% | 116,200 | -5.1% | 0.03% | 0.0% |
| Q2 2016 | $5,535,000 | +104.8% | 122,400 | +86.0% | 0.03% | +94.1% |
| Q1 2016 | $2,703,000 | +471.5% | 65,800 | +430.6% | 0.02% | +466.7% |
| Q4 2015 | $473,000 | +16.2% | 12,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $407,000 | -87.5% | 12,400 | -76.3% | 0.00% | -87.0% |
| Q2 2015 | $3,268,000 | +284.9% | 52,400 | +322.6% | 0.02% | +283.3% |
| Q1 2015 | $849,000 | -12.2% | 12,400 | -6.1% | 0.01% | -14.3% |
| Q4 2014 | $967,000 | -3.8% | 13,200 | -5.7% | 0.01% | -12.5% |
| Q3 2014 | $1,005,000 | 0.0% | 14,000 | +0.7% | 0.01% | +14.3% |
| Q2 2014 | $1,005,000 | -13.6% | 13,900 | -12.0% | 0.01% | -22.2% |
| Q1 2014 | $1,163,000 | +5.8% | 15,800 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $1,099,000 | -4.9% | 15,800 | -10.2% | 0.01% | 0.0% |
| Q3 2013 | $1,156,000 | -24.5% | 17,600 | -20.4% | 0.01% | -25.0% |
| Q2 2013 | $1,531,000 | – | 22,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |